Clinical Trials Logo
  1. Home
  2. Pregnancy Loss
  3. NCT03433989

ACTRAMAT-D: Impact of Post-Traumatic Stress Disorder After Pregnancy Loss After 12 Weeks of Gestation — ACTRAMAT-D  

Pregnancy Loss Clinical Trial

Official title:
Impact of Post-Traumatic Stress Disorder After Pregnancy Loss After 12 Weeks of Gestation (Termination of Pregnancy , Stillbirth, Late Miscarriage)

Clinical Trial Summary

In France The prevalence of Pregnancy Loss after 12 weeks of gestation is around 3%. This situation is probably associated to a risk of post-traumatic stress disorder.

As a part of the medical staff midwives are often confronted with this situation, however they can have difficulties to identify short and long term effects of a post-traumatic stress disorders.

The purpose of the present study is to estimate and analyze the prevalence of short-term (1 month) post-traumatic stress disorder in women with pregnancy loss after 12 weeks of gestation.The symptoms of post-traumatic stress disorder will be tracked using the Impact of Event Scale-revisited and the Peritraumatic Dissociative Experiences Questionnaires.The diagnosis of post-traumatic stress disorder will also be clinically confirmed by a psychiatrist during a specific consultation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03433989
Study type Interventional
Source University Hospital, Angers
Contact
Status Completed
Phase N/A
Start date March 7, 2018
Completion date February 21, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00954811 - Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF) Phase 4
Completed NCT00194844 - Couples Miscarriage Healing Project:Randomized Trial Phase 1/Phase 2
Completed NCT03712683 - Thyroxin in Subclinical Hypothyroidism N/A
Not yet recruiting NCT05039853 - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task N/A
Withdrawn NCT00771511 - Cervical Capsaicin for Labor Induction and Pain Relief Phase 4
Terminated NCT03100123 - AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study Early Phase 1
Active, not recruiting NCT05108675 - Microbiome and Malnutrition in Pregnancy (MMiP)
Completed NCT03585023 - Infections and Pregnancy Loss: Correlation Between Abortion and Silent Infections.
Completed NCT05430633 - Laparoscopic Versus Open Appendectomy in Pregnancy
Completed NCT00583635 - Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia N/A
Active, not recruiting NCT04360564 - RPL: Interval to Live Birth and Adverse Perinatal Outcomes
Terminated NCT03354832 - In-utero Death and Birth Mortality in Reunion Island
Recruiting NCT05284305 - Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Completed NCT03948022 - Luteal Support in Frozen-Thawed Embryo Transfer Cycles Phase 4
Active, not recruiting NCT05418140 - Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
Completed NCT05344144 - EFT and Music on Psychological Development, Well-Being Status and Cortisol Level in Pregnant Women N/A
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Completed NCT04910958 - Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
Completed NCT04017754 - Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)